Literature DB >> 23363344

Flow cytometric detection and procoagulant activity of circulating canine platelet-derived microparticles.

Sarah E Helmond1, James L Catalfamo, Marjory B Brooks.   

Abstract

OBJECTIVE: To measure platelet membrane-derived microparticle (PMP) content and thrombin-generating capacity of canine plasma subjected to specific processing and storage conditions. ANIMALS: 31 clinically normal dogs (19 males and 12 females). PROCEDURES: Citrate-anticoagulated blood samples obtained from each dog were centrifuged at 2,500 × g to isolate platelet-poor plasma (PPP), then PPP was centrifuged at 21,000 × g to isolate microparticle-free plasma (MPF) and microparticle-enriched plasma (MPEP). Whole blood and paired samples of fresh and frozen-thawed PPP, MPF, and MPEP were dual labeled for flow cytometric detection of membrane CD61 (constitutive platelet antigen) and annexin V (indicating phosphatidylserine externalization). Platelets and PMPs were enumerated with fluorescent, size-calibrated beads. Thrombin generation in fresh and frozen-thawed PPP, MPF, and MPEP was measured via kinetic fluorometric assays configured with low tissue factor and low phospholipid concentrations.
RESULTS: Initial centrifugation yielded PPP with < 0.5% the platelets of whole blood, with median counts of 413 PMPs/μL for males and 711 PMPs/μL for females. Sequential centrifugation resulted in a 10-fold concentration of PMPs in MPEP and virtually depleted PMPs from MPF. Thrombin generation depended on PMP content, with median endogenous thrombin potential of 0, 893, and 3,650 nmol•min for MPF, PPP, and MPEP, respectively. Freeze-thaw cycling caused significant increases in PMP counts and phosphatidylserine externalization. CONCLUSIONS AND CLINICAL RELEVANCE: Canine PMPs were major determinants of thrombin-generating capacity; preanalytic variables influenced plasma PMP content. Processing conditions described here may provide a basis for characterization of PMPs in clinical studies of thrombosis in dogs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363344     DOI: 10.2460/ajvr.74.2.207

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  In vitro properties of concentrated canine platelets stored in two additive solutions: a comparative study.

Authors:  N Hlavac; C S Lasta; M L Dalmolin; L A Lacerda; D de Korte; N A Marcondes; S R Terra; F B Fernandes; F H D González
Journal:  BMC Vet Res       Date:  2017-11-15       Impact factor: 2.741

Review 2.  Extracellular Vesicles: Evolutionarily Conserved Mediators of Intercellular Communication.

Authors:  Charlotte Lawson; Dory Kovacs; Elizabeth Finding; Emily Ulfelder; Virginia Luis-Fuentes
Journal:  Yale J Biol Med       Date:  2017-09-25

3.  Extracellular Vesicles in the Blood of Dogs with Cancer-A Preliminary Study.

Authors:  Magdalena Żmigrodzka; Olga Witkowska-Piłaszewicz; Alicja Rzepecka; Anna Cywińska; Dariusz Jagielski; Anna Winnicka
Journal:  Animals (Basel)       Date:  2019-08-19       Impact factor: 2.752

4.  The canine activated platelet secretome (CAPS): A translational model of thrombin-evoked platelet activation response.

Authors:  Signe E Cremer; James L Catalfamo; Robert Goggs; Stefan E Seemann; Annemarie T Kristensen; Paulina B Szklanna; Patricia B Maguire; Marjory B Brooks
Journal:  Res Pract Thromb Haemost       Date:  2020-12-03

5.  Persistent hypercoagulability in dogs envenomated by the European adder (Vipera berus berus).

Authors:  Hannah J Harjen; Marit Hellum; Runa Rørtveit; Malin Oscarson; Kristin P Anfinsen; Elena R Moldal; Susanna Solbak; Sandip M Kanse; Carola E Henriksson
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

Review 6.  Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation.

Authors:  Fumin Yuan; Ya-Min Li; Zhuhui Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.